(Q35217801)

English

Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer (English)
Anthony El-Khoueiry

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit